Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand

Optimal cumulative dose of cisplatin for concurrent chemoradiotherapy among patients with non-metastatic nasopharyngeal carcinoma: a multicenter analysis in Thailand

Abstract Background Chemoradiotherapy (CRT) with high cumulative doses (CDs) of cisplatin has been considered the standard of care for non-metastatic nasopharyngeal carcinoma (NPC). However, given most patients’ inability to tolerate high CDs due to cisplatin-related toxicities, the optimal CD of ci...

Full description

Bibliographic Details
Main Authors: Nuttapong Ngamphaiboon, Arunee Dechaphunkul, Jiraporn Setakornnukul, Tanadech Dechaphunkul, Rungarun Jiratrachu, Bhoom Suktitipat, Chuleeporn Jiarpinitnun, Poompis Pattaranutaporn, Pongwut Danchaivijitr
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Cancer
Subjects:
Nasopharyngeal carcinoma
Cisplatin
Chemoradiotherapy
Cumulative dose
Nephrotoxicity
Online Access:http://link.springer.com/article/10.1186/s12885-020-07024-8

Internet

http://link.springer.com/article/10.1186/s12885-020-07024-8

Similar Items